Reduction of Serum Melatonin Levels in HIV-1-Infected Individuals' Parallel Disease Progression: Correlation with Serum Interleukin-12 Levels

Infection

Volumn 31, Issue 6, 2003, Pages 379-382

  Nunnari, G ^a   Nigro, L ^b   Palermo, F ^b   Leto, D ^b   Pomerantz, R J ^a   Cacopardo, B ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; MELATONIN;

ADULT; ARTICLE; CELLULAR IMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PINEAL BODY; SEROLOGY; TH1 CELL; TH2 CELL;

EID: 0347477333     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-003-4038-9     Document Type: Article

References (23)

1. Maestroni GJM: The immunoendocrine role of melatonin. J Pineal Res 1993; 14: 1-10.
2. Gonzales Haba MG, Garcia Mauriño S, Calvo JR, et al.: High-affinity binding of melatonin by human circulating T-lymphocytes. FASEB J 1995; 9: 1331-1335.
3. Garcia-Mauriño S, Gonzalez-Haba MG, Calvo JR, et al.: Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol 1997; 159: 574-581.
4. Garcia-Mauriño S, Pozo D, Carrillo-Vico A, et al.: Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci 1999; 65: 2143-2150.
5. Clerici M, Balotta C, Salvaggio A, et al.: Human immunodeficiency virus (HIV) phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 1996; 88: 574-579.
6. Gazzinelli RT, Bala S, Stevens R, et al.: HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. J Immunol 1995; 155: 1565-1574.
7. Marshall JD, Chehimi J, Gri G, et al.: The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood 1999; 94: 1003-1011.
8. Arendt J, Wirz Justice A, Bradtke J, et al.: Long-term studies on immunoreactive human melatonin. Ann Clin Biochem 1979; 16: 307-312.
9. Petrovsky N, Harrison LC: Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J Immunol 1997; 158: 5163-5168.
10. Lissoni P, Rovelli F, Brivio F, et al.: Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humans. Nature Immunol 1998; 16: 1-5.
11. Valero N, Bonilla E, Pons H, et al.: Melatonin induces changes to serum cytokines in mice infected with the Venezuelan equine encephalomyelitis virus. Trans R Soc Trop Med Hyg 2002; 96: 348-351.
12. Kuhlwein E, Irwin M: Melatonin modulation of lymphocyte proliferation and Th1-Th2 cytokine expression. J Neuroimmunol 2001; 117: 51-57.
13. Seder RA, Gazzinelli R, Sher A, et al.: Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci U S A 1993; 90: 10188-10192.
14. Wu CY, Demeure C, Kiniwa M, et al.: IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J Immunol 1993; 151: 1938-1949.
15. Mulroney SE, McDonnell KJ, Pert CB, et al.: HIV gp120 inhibits the somatotropic axis: a possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting. Proc Natl Acad Sci U S A 1998; 95: 1927-1932.
16. Lortholary O, Christeff N, Casassus P, et al.: Hypothalamo-pituitary- adrenal function in human immunodeficiency virus-infected men. J Clin Endocrinol Metab 1996; 81: 791-796.
17. Lissoni P: The pineal gland as a central regulator of cytokine network. Neuroendocrinol Lett 1999; 20: 343-349.
18. Maestroni GJM, Conti A, Lissoni P: Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin-4. Cancer Res 1994; 54: 4734-4740.
19. Maestroni GJM, Covacci V, Conti A: A hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating-factor induced by the pineal neurohormone melatonin in tumor-bearing mice. Cancer Res 1994; 54: 2429-2432.
20. Del Gobbo V, Libri V, Villani N, et al.: Pinealectomy inhibits interleukin 2 production and natural killer cell activity in mice. Int J Immunopharmacol 1989; 11: 567-573.
21. Morrey KM, McLachan JA, Serkin CD, et al.: Activation of human monocytes by the pineal hormone melatonin. J Immunol 1994; 153: 2671-2680.
22. Sainz RM, Mayo JC, Uria H,et al.: The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis of thymocytes. J Pineal Res 1995; 19: 178-188.
23. 3: a biological phase-II study. J Biol Regul Homeost Agents 1995; 9: 155.